A breathalyzer for disease - Rapid, non-invasive detection of volatile markers of disease.
Owlstone is developing a cancer breathalyzer with a goal of saving 10,000 lives and £245M by 2020 through improved rates of early detection. The talk will outline the core chemical sensor technology and clinical data to date.
